C3is Earnings Calls
| Release date | May 18, 2026 |
| EPS estimate | - |
| EPS actual | $5.24 |
| Revenue estimate | - |
| Revenue actual | 11.576M |
| Release date | Feb 19, 2026 |
| EPS estimate | - |
| EPS actual | -$34.03 |
| Revenue estimate | - |
| Revenue actual | 10.554M |
| Release date | Nov 18, 2025 |
| EPS estimate | - |
| EPS actual | -$11.60 |
| Revenue estimate | - |
| Revenue actual | 4.794M |
| Release date | Sep 02, 2025 |
| EPS estimate | - |
| EPS actual | -$10.20 |
| Revenue estimate | - |
| Revenue actual | 10.737M |
Last 4 Quarters for C3is
Below you can see how CISS performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Sep 02, 2025 |
| Price on release | $408.10 |
| EPS estimate | - |
| EPS actual | -$10.20 |
| Date | Price |
|---|---|
| Aug 26, 2025 | $420.00 |
| Aug 27, 2025 | $420.24 |
| Aug 28, 2025 | $418.60 |
| Aug 29, 2025 | $421.81 |
| Sep 02, 2025 | $408.10 |
| Sep 03, 2025 | $401.80 |
| Sep 04, 2025 | $302.40 |
| Sep 05, 2025 | $292.60 |
| Sep 08, 2025 | $295.40 |
| 4 days before | -2.83% |
| 4 days after | -27.62% |
| On release day | -1.54% |
| Change in period | -29.67% |
| Release date | Nov 18, 2025 |
| Price on release | $235.20 |
| EPS estimate | - |
| EPS actual | -$11.60 |
| Date | Price |
|---|---|
| Nov 12, 2025 | $273.00 |
| Nov 13, 2025 | $247.80 |
| Nov 14, 2025 | $231.00 |
| Nov 17, 2025 | $235.20 |
| Nov 18, 2025 | $235.20 |
| Nov 19, 2025 | $231.00 |
| Nov 20, 2025 | $205.80 |
| Nov 21, 2025 | $218.40 |
| Nov 24, 2025 | $227.50 |
| 4 days before | -13.85% |
| 4 days after | -3.27% |
| On release day | -1.79% |
| Change in period | -16.67% |
| Release date | Feb 19, 2026 |
| Price on release | $15.33 |
| EPS estimate | - |
| EPS actual | -$34.03 |
| Date | Price |
|---|---|
| Feb 12, 2026 | $10.85 |
| Feb 13, 2026 | $10.57 |
| Feb 17, 2026 | $10.64 |
| Feb 18, 2026 | $11.69 |
| Feb 19, 2026 | $15.33 |
| Feb 20, 2026 | $13.58 |
| Feb 23, 2026 | $13.02 |
| Feb 24, 2026 | $12.32 |
| Feb 25, 2026 | $12.32 |
| 4 days before | 41.29% |
| 4 days after | -19.63% |
| On release day | -11.42% |
| Change in period | 13.55% |
| Release date | May 18, 2026 |
| Price on release | $3.17 |
| EPS estimate | - |
| EPS actual | $5.24 |
| Date | Price |
|---|---|
| May 12, 2026 | $3.31 |
| May 13, 2026 | $3.23 |
| May 14, 2026 | $3.19 |
| May 15, 2026 | $3.05 |
| May 18, 2026 | $3.17 |
| May 19, 2026 | $2.57 |
| May 20, 2026 | $2.63 |
| May 21, 2026 | $2.54 |
| May 22, 2026 | $2.36 |
| 4 days before | -4.23% |
| 4 days after | -25.55% |
| On release day | -18.93% |
| Change in period | -28.70% |
C3is Earnings Call Transcript Summary of Q1 2026
C3IS reported strong Q1 2026 results driven by higher charter rates and fleet expansion. Key financials: adjusted net income $5.5M (up 358% YoY), adjusted EBITDA $6.9M (up 130% YoY), voyage revenues $11.6M (up 34% YoY), fleet TCE up ~99% (fleet) and 106% (Aframax). Cash rose to $27M (up 82% vs year-end 2025) and fleet operational utilization was 85% for the quarter. Fleet expansion: company now operates 4 vessels (3 handysize dry bulk, 1 Aframax) and has acquired 2 product tankers (Clean Fury delivered in Q2 2026; second tanker expected in Q3 2026), increasing capacity ~387% since inception. Balance sheet/other items: vessels net book value ~$76M, warrant liability ~$1.7M (non-cash fair value changes, $2.3M loss in Q1 2026 vs prior year gain), no bank debt, upcoming CapEx obligations of $39.7M due Jan 2027 related to the two product tankers. Market environment: geopolitical tensions (Middle East conflict, Strait of Hormuz, Red Sea disruptions, Houthi attacks) have materially increased ton-mile demand and charter rates but have also raised bunker costs and input-cost uncertainty. Risks and considerations: continued geopolitical disruption and bunker price volatility, potential delays/slippage in newbuilding deliveries across the market, and non-cash warrant valuation volatility impacting reported results.
Sign In
Buy CISS